Global Clinical Trials Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2022 to 2028

Description

List of Tables

Value Market Research deeply researched the Global Clinical Trials Market to foresee a significant growth in the industry over the upcoming years. The global clinical trials market report provides a complete industry analysis, market size, market share, growth trends, and forecasts for 2023 to 2028. The report starts with a detailed market introduction and an executive summary that highlights the report's key growth numbers. The subsequent chapters discuss the value chain of the market, Porter's Five Forces Model, and market attractiveness analysis. An exclusive chapter on COVID-19 impact analysis has been added to understand how the market has responded to the pandemic.

The market dynamics section of the report elaborates the current market drivers, restraints along with the challenges/risks and upcoming opportunities. This section can be of high interest for any company's strategists and new product development department. The global clinical trials market study segments the market and provides the market size in terms of revenue and/ or sales. This data is bifurcated by region and later by countries. The data is collected through detailed primary interviews and industry experts across the world. The detailed methodology can be seen in our sample reports. These market estimates are also influenced by the latest social, political and economic changes along with the current market dynamics that are affecting this clinical trials market.

The next sections of the clinical trials market report studies the market competitiveness and profiles some key market players/manufacturers. These sections are knowledgeable for understanding the competitor's product-line, their financials, recent developments and the top market share owners in the industry.

Countries Covered in the report are as below:

North America - United States, Canada, and Mexico

Europe - United Kingdom, Germany, France, Italy, Russia, Spain & Rest of Europe

Asia-Pacific - China, India, Japan, South Korea, Australia & Rest of APAC

Latin America - Brazil, Argentina, Peru, Chile & Rest of Latin America

Middle East and Africa - Saudi Arabia, UAE, Israel, South Africa

Market Segmentation in the report is as below:

By Phase

Phase I

Phase II

Phase III

Phase IV

By Study Design

Interventional

Observational

Expanded Access

By Indication

Autoimmune/Inflammation

Pain Management

Oncology

CNS Condition

Diabetes

Obesity

Cardiovascular

Product Code: VMR11210536

1 . PREFACE

1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

2.1. Highlights of Clinical Trials Market
2.2. Global Clinical Trials Market Snapshot

3 . CLINICAL TRIALS - INDUSTRY ANALYSIS

3.1. Introduction
3.2. Market Drivers of Clinical Trials Market
3.3. Market Restraints of Clinical Trials Market
3.4. Opportunities of Clinical Trials Market
3.5. Trends of Clinical Trials Market
3.6. Porter's Five Force Analysis of Clinical Trials Market
3.7. Clinical Trials Market Attractiveness Analysis
- 3.7.1 Market Attractive Analysis by Phase
- 3.7.2 Market Attractive Analysis by Study Design
- 3.7.3 Market Attractive Analysis by Indication
- 3.7.4 Market Attractive Analysis by Region

4 . VALUE CHAIN ANALYSIS

4.1. Clinical Trials Value Chain Analysis
4.2. Clinical Trials Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Clinical Trials Raw Material Manufactures List
- 4.2.3. Price Trend of Clinical Trials Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend

5 . GLOBAL CLINICAL TRIALS MARKET ANALYSIS BY PHASE

5.1 Overview by Phase
5.2 Global Clinical Trials Market Analysis by Phase
5.3 Market Analysis of Phase I by Regions
5.4 Market Analysis of Phase II by Regions
5.5 Market Analysis of Phase III by Regions
5.6 Market Analysis of Phase IV by Regions

6 . GLOBAL CLINICAL TRIALS MARKET ANALYSIS BY STUDY DESIGN

6.1 Overview by Study Design
6.2 Global Clinical Trials Market Analysis by Study Design
6.3 Market Analysis of Interventional by Regions
6.4 Market Analysis of Observational by Regions
6.5 Market Analysis of Expanded Access by Regions

7 . GLOBAL CLINICAL TRIALS MARKET ANALYSIS BY INDICATION

7.1 Overview by Indication
7.2 Global Clinical Trials Market Analysis by Indication
7.3 Market Analysis of Autoimmune/Inflammation by Regions
7.4 Market Analysis of Pain Management by Regions
7.5 Market Analysis of Oncology by Regions
7.6 Market Analysis of CNS Condition by Regions
7.7 Market Analysis of Diabetes by Regions
7.8 Market Analysis of Obesity by Regions
7.9 Market Analysis of Cardiovascular by Regions

8 . GLOBAL CLINICAL TRIALS MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America
- 8.3.1. Overview
- 8.3.2. North America Clinical Trials Market Estimate by Country
- 8.3.3. United State
- 8.3.4. Rest of North America
8.4. Europe
- 8.4.1. Overview
- 8.4.2. Europe Clinical Trials Market Estimate by Market Segment
- 8.4.3. Europe Clinical Trials Market Estimate by Country
- 8.4.4. United Kingdom
- 8.4.5. France
- 8.4.6. Germany
- 8.4.7 Rest of Europe
8.5. Asia Pacific
- 8.5.1. Overview
- 8.5.2. Asia Pacific Clinical Trials Market Estimate by Market Segment
- 8.5.3. Asia Pacific Clinical Trials Market Estimate by Country
- 8.5.4. China
- 8.5.5. Japan
- 8.5.6. India
- 8.5.7. Rest of Asia Pacific
8.6. Latin America
- 8.6.1. Overview
- 8.6.2. Latin America Clinical Trials Market Estimate by Market Segment
- 8.6.3. Latin America Clinical Trials Market Estimate by Country
- 8.6.4. Brazil
- 8.6.5. Rest of Latin America
8.7. Middle East & Africa
- 8.7.1. Overview
- 8.7.2. Middle East & Africa Clinical Trials Market Estimate by Market Segment
- 8.7.3. Middle East & Africa Clinical Trials Market Estimate by Country
- 8.7.4. Middle East
- 8.7.5. Africa

9 . COMPETITIVE LANDSCAPE OF THE CLINICAL TRIALS COMPANIES

9.1. Clinical Trials Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10 . COMPANY PROFILES OF CLINICAL TRIALS INDUSTRY

10.1. Company Share Analysis
10.2. Market Concentration Rate
10.3. Charles River Laboratories
- 10.3.1. Company Overview
- 10.3.2. Financials
- 10.3.3. Products
- 10.3.4. Recent Developments
10.4. ICON plc
- 10.4.1. Company Overview
- 10.4.2. Financials
- 10.4.3. Products
- 10.4.4. Recent Developments
10.5. Paraxel International Corporation
- 10.5.1. Company Overview
- 10.5.2. Financials
- 10.5.3. Products
- 10.5.4. Recent Developments
10.6. Quintiles IMS
- 10.6.1. Company Overview
- 10.6.2. Financials
- 10.6.3. Products
- 10.6.4. Recent Developments
10.7. SGS SA
- 10.7.1. Company Overview
- 10.7.2. Financials
- 10.7.3. Products
- 10.7.4. Recent Developments
10.8. Others
- 10.8.1. Company Overview
- 10.8.2. Financials
- 10.8.3. Products
- 10.8.4. Recent Developments

11. IMPACT ANALYSIS OF COVID-19 OUTBREAK

11.1. Impact Analysis of Covid-19 Outbreak on the Market
- 11.1.1. Direct Impact on Production
- 11.1.2. Supply Chain and Market Disruption
- 11.1.3. Financial Impact on Firms and Financial Markets
11.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
11.3. Pre V/S Post COVID-19 Market
11.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Market Size in 2020, by Scenario
11.5. COVID-19: Micro and Macro Factor Analysis on the Market

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies